Ruffo Frank

CIK 00016544501 companyMALVERN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001654450

Recent Transactions

50 trades

Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-03-10$15.55/sh−12,823→ 201,883 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-03-02+8,297→ 214,706 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2022-03-02−8,297→ 16,595 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2022-03-01−25,750→ 25,750 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-03-01+25,750→ 198,109 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-03-01+8,300→ 206,409 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2022-03-01+44,300→ 44,300 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2022-03-01−8,300→ 24,900 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2022-03-01+155,200→ 155,200 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-02-09$12.66/sh−1,388→ 172,359 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-02-01+3,875→ 173,747 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-02-01−3,875→ 0 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-02$21.51/sh−12,587→ 172,322 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-02$22.30/sh−2,450→ 169,872 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-01−33,189→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-01+33,189→ 184,909 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-04-26$26.44/sh−100→ 151,720 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-04-26$25.79/sh−27,239→ 151,820 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-04-23$26.64/sh−29,200→ 179,859 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-04-23$27.33/sh−800→ 179,059 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-04-22$26.84/sh−30,000→ 209,059 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-03-02+8,297→ 241,903 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-03-02$23.25/sh−2,844→ 239,059 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2021-03-02−8,297→ 24,892 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2021-03-01+116,000→ 116,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-03-01+25,750→ 240,939 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-03-01$24.06/sh−7,333→ 233,606 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2021-03-01−25,750→ 51,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2021-03-01+33,200→ 33,200 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-02-01−3,875→ 3,875 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-02-01+3,875→ 216,497 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-02-01$21.35/sh−1,308→ 215,189 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-12-15+1,300→ 212,992 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2020-12-15−1,300→ 0 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-12-15$4.59/sh−370→ 212,622 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-06-01−33,188→ 33,189 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-01+33,188→ 221,143 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-01$1.32/sh−9,451→ 211,692 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02−25,750→ 77,250 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+33,189→ 33,189 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+66,377→ 66,377 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2020-03-02+116,160→ 116,160 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02+25,750→ 195,117 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02$1.26/sh−7,162→ 187,955 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-02-03+3,875→ 170,675 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2020-02-03−3,875→ 7,750 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-02-03$1.28/sh−1,308→ 169,367 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2019-12-18−1,250→ 0 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2019-12-18$1.81/sh−356→ 166,800 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2019-12-18+1,250→ 167,156 total

Companies

Aclaris Therapeutics, Inc.
Chief Financial Officer
$ACRS

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400

MALVERN, PA, 19355

View on SEC.gov